Advertisement

Prognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: impact of baseline fluctuation and changes during chemotherapy

Abstract

Aims and background. Inflammation has been implicated in carcinogenesis and progression of pancreatic cancer. The neutrophil-to-lymphocyte ratio is an index of systemic inflammation. We examined the prognostic role of the neutrophil-to-lymphocyte ratio at baseline and the significance of intrapersonal variability of the ratio before and during chemotherapy.
Methods and study design. Advanced pancreatic adenocarcinoma patients who had received chemotherapy were included. Baseline clinical and biochemical parameters, including the neutrophil-to-lymphocyte ratio, were extracted and analyzed. The neutrophil-to-lymphocyte ratio threshold was determined via recursive partitioning and assessed at diagnosis, prior to chemotherapy and during treatment. Overall survival was estimated via the Kaplan-Meier method and compared between groups with the logrank test.
Results. Between 2005 and 2011, 85 patients with locally advanced (n = 38) and metastatic disease were identified: 68% with a neutrophil-to-lymphocyte ratio >3 had shorter median overall survival than patients with a neutrophil-to-lymphocyte ratio >3 (3.4 vs 9.4 months, P = 0.001). Pretreatment, 35% of repeat neutrophil-to-lymphocyte ratios crossed the threshold of 3. A persistently elevated neutrophil-to-lymphocyte ratio >3 suggested a worse overall survival than in patients with a decreasing, increasing or persistently low neutrophil-to-lymphocyte ratio (1.9 vs 8.2, 12.3 and 11.7 months, respectively, P >0.001). Twenty-three percent of patients had a >50% decrease in neutrophil-to-lymphocyte ratio following 4 weeks of chemotherapy, with a trend towards improvement in overall survival (12.5 vs 5.0 mo, P = 0.068).
Conclusions. The baseline neutrophil-to-lymphocyte ratio is a validated marker for a poor prognosis. Multiple assessments of the pre-treatment neutrophil-to-lymphocyte ratio might be required. Reduction in the neutrophil-to-lymphocyte ratio during chemotherapy may be associated with improved survival.

Tumori 2013; 99(4): 516 - 522

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1361.15104

Authors

MinYuen Teo, Mohd Syahizul Nuhairy Mohd Sharial, Felicity McDonnell, Kevin C Conlon, Paul F Ridgway, Ray S McDermott

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Teo, MinYuen [PubMed] [Google Scholar]
    Department of Medical Oncology, Adelaide & Meath Hospital incorporating National Children’s Hospital, Tallaght, Dublin, Ireland
  • Mohd Sharial, Mohd Syahizul Nuhairy [PubMed] [Google Scholar]
    Department of Medical Oncology, Adelaide & Meath Hospital incorporating National Children’s Hospital, Tallaght, Dublin, Ireland
  • McDonnell, Felicity [PubMed] [Google Scholar]
    Pharmacy Department, Adelaide & Meath Hospital incorporating National Children’s Hospital, Tallaght, Dublin, Ireland
  • Conlon, Kevin C [PubMed] [Google Scholar]
    Professorial Surgical Unit and Department of Upper Gastrointestinal & Hepato-Pancreato-Biliary Surgery, Adelaide & Meath Hospital incorporating National Children’s Hospital, Tallaght, Dublin, Ireland
  • Ridgway, Paul F [PubMed] [Google Scholar]
    Professorial Surgical Unit and Department of Upper Gastrointestinal & Hepato-Pancreato-Biliary Surgery, Adelaide & Meath Hospital incorporating National Children’s Hospital, Tallaght, Dublin, Ireland
  • McDermott, Ray S [PubMed] [Google Scholar]
    Department of Medical Oncology, Adelaide & Meath Hospital incorporating National Children’s Hospital, Tallaght, Dublin, Ireland

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.